An Open-Label, Single-Sequence Study to Investigate the Effects of Cyclosporine on the Pharmacokinetics of BMS-986165 at Steady State in Healthy Male Participants.
Phase of Trial: Phase I
Latest Information Update: 31 May 2018
At a glance
- Drugs BMS 986165 (Primary) ; Ciclosporin
- Indications Plaque psoriasis; Psoriasis
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 25 May 2018 Status changed from recruiting to completed.
- 08 May 2018 Planned End Date changed from 11 Apr 2018 to 16 May 2018.
- 08 May 2018 Planned primary completion date changed from 10 Apr 2018 to 16 May 2018.